1. ARDD 2020: from aging mechanisms to interventions
- Author
-
Wei Wu He, Brenna Osborne, Dario Riccardo Valenzano, Lene Juel Rasmussen, Rafael de Cabo, Dudley W. Lamming, Jim Mellon, Evandro Fei Fang, Marсo Demaria, Aubrey de Grey, Andrey A. Parkhitko, Lei Zhang, Sergey Young, Nanna MacAulay, Vera Gorbunova, Martin Borch Jensen, Jonas T. Treebak, Alexey Moskalev, Judith Campisi, Anais Franco-Romero, Nuno Raimundo, Collin Y. Ewald, Morten Scheibye-Knudsen, Riekelt H. Houtkooper, Majken K. Jensen, Luigi Ferrucci, Kai Fu Lee, Jan H.J. Hoeijmakers, Eva Hoffmann, Carolina Reis, Søren Brunak, Thomas A. Rando, David A. Sinclair, David J. Glass, Daniela Bakula, Adam Freund, Pam R. Taub, Brian K. Kennedy, Yousin Suh, Moustapha Kassem, Kotb Abdelmohsen, Polina Mamoshina, Björn Schumacher, Debra Toiber, Ana Maria Cuervo, Gerard Karsenty, Peter L.J. de Keizer, Laura J. Niedernhofer, Ieva Bagdonaite, Christian G. Riedel, Steve Horvath, Richard G. A. Faragher, Carlos G. Silva-García, Vadim N. Gladyshev, Alice E. Kane, Anastasia Georgievskaya, Eric Verdin, Marte Molenaars, Nir Barzilai, Filipe Cabreiro, Heidi H. Pak, Pénélope Andreux, Garik Mkrtchyan, Alex Zhavoronkov, Andreas Mund, Jan Vijg, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Restoring Organ Function by Means of Regenerative Medicine (REGENERATE), Molecular Genetics, Health Economics (HE), Laboratory Genetic Metabolic Diseases, ACS - Diabetes & metabolism, ACS - Heart failure & arrhythmias, APH - Aging & Later Life, and AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
- Subjects
Screening techniques ,Aging ,Artificial intelligence ,Geriatrics & Gerontology ,Biomedical Research ,Emerging technologies ,Physiology ,Oncology and Carcinogenesis ,Longevity ,Columbia university ,Psychological intervention ,INHIBITION ,SUFFICIENT ,aging ,artificial intelligence ,drug discovery ,interventions ,Cellular Senescence ,Congresses as Topic ,Drug Discovery ,Humans ,Life Style ,Pharmaceutical Preparations ,Artificial Intelligence ,METABOLISM ,Meeting Report ,0601 Biochemistry and Cell Biology ,AGE ,Industry sector ,Political science ,1112 Oncology and Carcinogenesis ,Interventions ,LIFE-SPAN ,Science & Technology ,business.industry ,Drug discovery ,Prevention ,SIGNATURE ,Cell Biology ,Public relations ,0606 Physiology ,Good Health and Well Being ,DNA-DAMAGE ,MITOPHAGY ,Biochemistry and Cell Biology ,business ,OSTEOCALCIN ,Life Sciences & Biomedicine ,Developmental Biology - Abstract
Aging is emerging as a druggable target with growing interest from academia, industry and investors. New technologies such as artificial intelligence and advanced screening techniques, as well as a strong influence from the industry sector may lead to novel discoveries to treat age-related diseases. The present review summarizes presentations from the 7th Annual Aging Research and Drug Discovery (ARDD) meeting, held online on the 1st to 4th of September 2020. The meeting covered topics related to new methodologies to study aging, knowledge about basic mechanisms of longevity, latest interventional strategies to target the aging process as well as discussions about the impact of aging research on society and economy. More than 2000 participants and 65 speakers joined the meeting and we already look forward to an even larger meeting next year. Please mark your calendars for the 8th ARDD meeting that is scheduled for the 31st of August to 3rd of September, 2021, at Columbia University, USA., Aging, 12 (24), ISSN:1945-4589
- Published
- 2020
- Full Text
- View/download PDF